Hosted on MSN1d
Abbott's Freestyle Libre CGMs Cleared for Use During Imaging Tests
But now, Abbott’s FreeStyle Libre 2 and 3 have received the first and only FDA clearance that allows patients to keep their ...
drugdeliverybusiness1d
The biggest diabetes tech stories of the year so far
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
drugdeliverybusiness16d
FDA approves Abbott CGMs for use during medical imaging
Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.
PharmiWeb15d
Abbott's FreeStyle Libre® 2 and 3: First Continuous Glucose Monitoring Systems Approved for Use During Medical Imaging
Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...
Medscape11d
Newer Abbott Libre CGM Sensor Use Now Okay During Imaging
The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...
Business Wire18d
Tidepool Will Integrate With Abbott’s FreeStyle Libre Portfolio for Seamless Cloud-to-Cloud Data
A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...
Beta Bionics Announces Launch of the iLet Bionic Pancreas With Abbott's FreeStyle Libre 3 Plus Sensor
IRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes ...
Two thirds of Brits with chronic health conditions are hiding it on dating apps
The research indicates that 1 in 10 think they've been refused a date because of health issues such as Type 2 diabetes.
Forbes25d
What Drove Abbott's Q3?
FreeStyle Libre continues to gain market share and driving the diabetes sales growth for Abbott. Abbott maintains its total 2024 revenue guidance of 9.5% to 10% growth on an organic basis.